We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
(+2.2%)
Cap. Flow
-$488M
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$101M |
| 2 |
GE Vernova
GEV
|
+$75.4M |
| 3 |
CRH
CRH
|
+$48.5M |
| 4 |
CrowdStrike
CRWD
|
+$45.8M |
| 5 |
Dell
DELL
|
+$35.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$180M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$121M |
| 3 |
GE Aerospace
GE
|
+$59.1M |
| 4 |
UnitedHealth
UNH
|
+$46.6M |
| 5 |
NVIDIA
NVDA
|
+$38.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.98% |
| 2 | Financials | 12.55% |
| 3 | Healthcare | 11.48% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Compass Therapeutics
CMPX
$387M
| $132K | ﹤0.01% |
131,789
+12,315
| +10% | +$18K |
|
3177
Copa Holdings
CPA
$5.8B
| $132K | ﹤0.01% |
1,382
+1,380
| +69,000% | +$138K |
|
3178
MediWound
MDWD
$185M
| $131K | ﹤0.01% |
+8,440
| New | +$140K |
|
3179
iShares S&P India Nifty 50 Index Fund
INDY
$569M
| $130K | ﹤0.01% |
2,430
| – | – |
|
3180
LiveWire
LVWR
$221M
| $130K | ﹤0.01% |
16,967
-3,898
| -19% | -$27.2K |
|
3181
JFrog
FROG
$10.8B
| $130K | ﹤0.01% |
3,459
-115
| -3% | -$4.21K |
|
|
QVCGA
3182
DELISTED
QVC Group Inc Series A
QVCGA
| $130K | ﹤0.01% |
4,116
-18
| -0.4% | -$748 |
|
3183
Everspin Technologies
MRAM
$405M
| $129K | ﹤0.01% |
+21,595
| New | +$143K |
|
3184
HUTCHMED
HCM
$2.17B
| $129K | ﹤0.01% |
7,553
+564
| +8% | +$10.4K |
|
3185
Torrid Holdings
CURV
$260M
| $129K | ﹤0.01% |
17,189
+45
| +0.3% | +$258 |
|
3186
Acumen Pharmaceuticals
ABOS
$176M
| $127K | ﹤0.01% |
+52,323
| New | +$167K |
|
3187
Energy Vault
NRGV
$633M
| $126K | ﹤0.01% |
133,125
-675
| -0.5% | -$838 |
|
3188
iQIYI
IQ
$1.28B
| $126K | ﹤0.01% |
34,443
-113,375
| -77% | -$512K |
|
3189
Priority Technology Holdings
PRTH
$444M
| $126K | ﹤0.01% |
23,782
+1,459
| +7% | +$5.52K |
|
3190
Ultralife
ULBI
$106M
| $125K | ﹤0.01% |
11,811
+11,165
| +1,728% | +$119K |
|
3191
Smith-Midland
SMID
$152M
| $125K | ﹤0.01% |
+4,528
| New | +$166K |
|
3192
Agnico Eagle Mines
AEM
$90.5B
| $125K | ﹤0.01% |
1,909
-570
| -23% | -$37.2K |
|
|
NAGE
3193
Niagen Bioscience
NAGE
$247M
| $124K | ﹤0.01% |
+45,519
| New | +$152K |
|
3194
Ispire Technology
ISPR
$98.2M
| $124K | ﹤0.01% |
15,464
+1,354
| +10% | +$8.73K |
|
|
BRFS
3195
DELISTED
BRF SA
BRFS
| $123K | ﹤0.01% |
30,301
-136,324
| -82% | -$479K |
|
3196
The ONE Group
STKS
$53M
| $123K | ﹤0.01% |
28,900
+971
| +3% | +$5.04K |
|
3197
Gyre Therapeutics
GYRE
$744M
| $123K | ﹤0.01% |
+10,291
| New | +$141K |
|
|
MPX
3198
DELISTED
Marine Products Corp
MPX
| $122K | ﹤0.01% |
12,119
-60
| -0.5% | -$646 |
|
|
PARAA
3199
DELISTED
Paramount Global Class A
PARAA
| $122K | ﹤0.01% |
6,638
+217
| +3% | +$4.58K |
|
3200
BCE
BCE
$21.2B
| $122K | ﹤0.01% |
3,756
-2
| -0.1% | -$67 |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2024 Portfolio in Review
As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
- RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
- RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
- RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
- RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
- RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.
Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.